Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada flag Canada · Delayed Price · Currency is CAD
2.750
-0.100 (-3.51%)
Oct 10, 2025, 2:20 PM EDT
-3.51%
Market Cap92.08M
Revenue (ttm)144.11M
Net Income (ttm)1.10M
Shares Out32.31M
EPS (ttm)0.04
PE Ratio73.49
Forward PE41.91
Dividendn/a
Ex-Dividend Daten/a
Volume27,519
Average Volume56,355
Open2.830
Previous Close2.850
Day's Range2.740 - 2.860
52-Week Range1.710 - 5.560
Beta1.91
RSI48.39
Earnings DateNov 5, 2025

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection ... [Read more]

Sector Healthcare
Founded 2018
Employees 91
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.